We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

GenomeQuest Upgrades Online Patent Search

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute
GenomeQuest has announced the immediate availability of GenomeQuest 6.3 for IP the latest version of its online IP sequence search product.

Overall GenomeQuest for IP offers researchers a comprehensive, easy-to-use research solution with unmatched content aggregation, search algorithms, and analysis tools. New capabilities offered in the 6.3 version include:

• Integration of DNA and Protein Searching -- researchers can now search IP databases of nucleotides and associated proteins simultaneously. The combined set of matches can be queried and analyzed as a single results database, saving time and errors associated with manually combining two different sets of results.

• Content Expansion -- over 265,000 patents are now stored in the GQ-PAT database, including sequences and all annotations. GQ-PAT now aggregates, normalizes, curates, and updates IP information across global databases, including USPTO, EPO, WIPO & PCT, INPADOC, GenBank, EMBL, DDBJ, and paper filings at WIPO.

• Enhanced Search and Analysis -- GQ-PAT offers multiple search algorithms, including BLAST, GenePast, and more. Each algorithm is suited to a different use case and works across the selected set of global databases.

• The result browser has been upgraded to the GenomeQuest 6.0 platform, allowing users to interactively query/filter/group on any field, quickly pinpoint matches of most interest, and generate comprehensive IP search reports. Multiple users can collaborate on shared datasets.

CEO Ron Ranauro comments, "With GenomeQuest for IP, pharmaceutical firms, biotech companies, and academia can use GenomeQuest as an integrated solution for all their IP sequence searching needs, including for IP validity, freedom-to-operate, and patent infringement. In fact, most are finding that by using GenomeQuest for IP they can perform all research from a web browser with zero IT costs and administration, increasing their productivity, and boosting the quality and frequency of their searches."

Additionally, GenomeQuest 6.3 for IP gives life sciences professionals Web-based access to Thomson Reuters’ GENESEQ database. The two companies are hosting free seminars to present that latest features and seamless integration between the two products, in South San Francisco (June 10) and Boston (June 22).